| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/05/2011 | CA2437788C Inflammation-inhibiting compounds |
| 04/05/2011 | CA2429027C Antibodies against human receptor h4-1bb |
| 04/05/2011 | CA2346119C A method of inducing or enhancing chondrogenesis with extracellular matrix containing gdf-5 |
| 04/05/2011 | CA2330916C Triterpene compositions and methods for use thereof |
| 04/05/2011 | CA2309355C Tissue cement proteins from rhipicephalus appendiculatus |
| 03/31/2011 | WO2011038300A1 Cancer stem cells, kits, and methods |
| 03/31/2011 | WO2011038278A2 Micelle encapsulation of therapeutic agents |
| 03/31/2011 | WO2011038133A2 Umbilical cord lining stem cells and methods and material for isolating and culturing same |
| 03/31/2011 | WO2011037835A2 Medium for handling and storing biological tissues of the musculoskeletal system outside an organism |
| 03/31/2011 | WO2011037416A2 Method of manufacturing cell spheroids which are mixed cellular complexes for cell transplantation and usage thereof |
| 03/31/2011 | WO2011037367A2 Highly-efficient manufacturing method of induced pluripotent stem cells and induced pluripotent stem cells produced by the method |
| 03/31/2011 | WO2011037301A1 Method for derivation of pluripotent stem cells from adult cells and pluripotent stem cells produced by method |
| 03/31/2011 | WO2011037271A1 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof |
| 03/31/2011 | WO2011037270A1 Method of efficiently establishing induced pluripotent stem cells |
| 03/31/2011 | WO2011037262A1 Hybridoma producing anti-methylated dna antibody and utilization of same |
| 03/31/2011 | WO2011036894A1 Virus gene for acquiring tenuivirus-resistant plant using rna interference technique |
| 03/31/2011 | WO2011036878A1 Amelioration of metabolic syndrome or method for screening for ameliorating agent for metabolic syndrome utilizing physiological function of sphingomyelin synthase sms2 |
| 03/31/2011 | WO2011036812A1 Cell, method and assay kit for measuring level of transcriptional activation of aryl hydrocarbon receptor |
| 03/31/2011 | WO2011036722A1 Enhancer of nk activity and use thereof |
| 03/31/2011 | WO2011036637A2 Cell culture medium |
| 03/31/2011 | WO2011035423A1 Method of preparing plant-derived proteins |
| 03/31/2011 | WO2010150013A3 Identification of sex-linked proteins |
| 03/31/2011 | WO2010141801A3 Reprogramming t cells and hematophietic cells |
| 03/31/2011 | WO2010135610A3 Cell therapy for brain tissue damage |
| 03/31/2011 | WO2010135401A3 Kinase-mediated cytoprotection and enhanced cellular engraftment and persistence |
| 03/31/2011 | WO2010132788A3 Assay for mutations in stem cells and their derivatives |
| 03/31/2011 | WO2010132708A3 Modulation of terminase activity at telomeres and dna double-strand breaks |
| 03/31/2011 | WO2010126278A3 Humanized nsg mouse, method of producing the same and use thereof |
| 03/31/2011 | WO2010124256A3 Methods and systems for identifying immunomodulatory substances |
| 03/31/2011 | WO2010123938A3 Bioresponsive hydrogel |
| 03/31/2011 | WO2010121122A3 Biomechanical induction of hematopoiesis |
| 03/31/2011 | WO2010121008A3 Methods for enhancing hematopoietic progenitor cell engraftment |
| 03/31/2011 | WO2010120785A3 Methods and compositions for stem cell cultures |
| 03/31/2011 | WO2010115167A3 Methods and devices for sorting cells and other biological particulates |
| 03/31/2011 | WO2010115050A3 Embryonic stem cell specific micrornas promote induced pluripotency |
| 03/31/2011 | WO2010108005A3 Novel neural progenitors from pluripotent stem cells, methods of producing same and use to produce neural cells |
| 03/31/2011 | WO2010107497A3 Honeycomb shrink wells for stem cell culture |
| 03/31/2011 | WO2010096170A3 Inhibition of trna synthetases and therapeutic applications thereof |
| 03/31/2011 | WO2010093802A3 Therapeutic method for increasing pancreatic beta cell mass |
| 03/31/2011 | WO2008020333A3 Nucleic acid encoding n-methylputrescine oxidase and uses thereof |
| 03/31/2011 | US20110078833 Genome wide identification and characterization of gene expression regulatory elements in zea mays for use in plants |
| 03/31/2011 | US20110078831 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 03/31/2011 | US20110078830 Polypeptides having xylanase activity and polynucleotides encoding same |
| 03/31/2011 | US20110078829 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 03/31/2011 | US20110078827 Plant transformation method |
| 03/31/2011 | US20110078821 Heat resistant plants and plant tissues and methods and materials for making and using same |
| 03/31/2011 | US20110078820 Methods and compositions for transgenic plants producing antimicrobial peptides for enhanced disease resistance |
| 03/31/2011 | US20110078815 Cytoplasmic male sterile rucola |
| 03/31/2011 | US20110078811 Cotton variety fm 9160b2f |
| 03/31/2011 | US20110078805 Compositions and methods for generating transgenic animals |
| 03/31/2011 | US20110078803 Sex selected equine embryo production system |
| 03/31/2011 | US20110077702 Means and Methods for Influencing Electrical Activity of Cells |
| 03/31/2011 | US20110077285 Rna antagonist compounds for the modulation of pik3ca expression |
| 03/31/2011 | US20110077269 Derivatives for modulation of ion channels |
| 03/31/2011 | US20110077268 Kinase inhibitors and methods of use |
| 03/31/2011 | US20110077265 Inhibitors of iap |
| 03/31/2011 | US20110077263 Methods and Compositions of Toll-Like Receptor (TLR) Agonists |
| 03/31/2011 | US20110077233 C-Met Modulators and Method of Use |
| 03/31/2011 | US20110077224 Linoleic phospholipids and uses thereof for inhibiting inflammatory and neurodegenerative processes |
| 03/31/2011 | US20110077208 Expression of secreted human alpha-fetoprotein in transgenic animals |
| 03/31/2011 | US20110077203 Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use |
| 03/31/2011 | US20110077201 High affinity vegf-receptor antagonists |
| 03/31/2011 | US20110077197 Novel insulin derivatives having an extremely delayed time-action profile |
| 03/31/2011 | US20110077196 Non-standard insulin analogues |
| 03/31/2011 | US20110077190 Selective Caspase Inhibitors and Uses Thereof |
| 03/31/2011 | US20110076773 Delivery of DNA or RNA via gap junctions from host cells to target cells and a cell-based delivery system for antisense or siRNA |
| 03/31/2011 | US20110076772 Methods of preparing nutritive media for growth and/or germination of plant embryos |
| 03/31/2011 | US20110076771 Tissue fiber scaffold and method for making |
| 03/31/2011 | US20110076770 Culturing method of mesenchymal stem cell |
| 03/31/2011 | US20110076769 Mammary artery derived cells and methods of use in tissue repair and regeneration |
| 03/31/2011 | US20110076768 Method for detecting carcinoma and agent for suppressing carcinoma |
| 03/31/2011 | US20110076767 Magnetically-driven biodegradable gene delivery nanoparticles formulated with surface-attached polycationic complex |
| 03/31/2011 | US20110076766 Cytostatic Drug Composition |
| 03/31/2011 | US20110076765 Method for increasing the activity of lysosomal enzymes |
| 03/31/2011 | US20110076764 Methods and kits for cell release |
| 03/31/2011 | US20110076763 Neoplasm specific antibodies and uses thereof |
| 03/31/2011 | US20110076762 Articles formed by manufacturing processes, such as three-dimensional printing, including solvent vapor filming and the like |
| 03/31/2011 | US20110076761 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers |
| 03/31/2011 | US20110076760 Viral expression plasmids for production of proteins, antibodies, enzymes, virus-like particles and for use in cell-based assays |
| 03/31/2011 | US20110076743 Three-dimensional structure of isoprene synthase and its use thereof for generating variants |
| 03/31/2011 | US20110076742 Polynucleotides encoding novel pcsk9 variants |
| 03/31/2011 | US20110076735 Microfluidic Devices |
| 03/31/2011 | US20110076730 Microbial synthesis of d-1,2,4-butanetriol |
| 03/31/2011 | US20110076723 Antibody-peptide fused synergibody |
| 03/31/2011 | US20110076722 Stable multivalent antibody |
| 03/31/2011 | US20110076713 Process of characterization of hepatocytes from goat |
| 03/31/2011 | US20110076705 Compositions and methods for early pregnancy diagnosis |
| 03/31/2011 | US20110076700 Anti-crp antibody and utilization of the same |
| 03/31/2011 | US20110076696 Cardiovascular safety assay |
| 03/31/2011 | US20110076683 Identification, Isolation and Elimination of Cancer Stem Cells |
| 03/31/2011 | US20110076681 Modified gene-silencing nucleic acid molecules and uses thereof |
| 03/31/2011 | US20110076678 Reprogramming of somatic cells |
| 03/31/2011 | US20110076668 Blood sample processing apparatus and blood sample processing method |
| 03/31/2011 | US20110076665 Electromagnetic controlled biofabrication for manufacturing of mimetic biocompatible materials |
| 03/31/2011 | US20110076329 Graft prosthesis, material and methods |
| 03/31/2011 | US20110076320 Stem cell cultivation devices and methods |
| 03/31/2011 | US20110076316 Scalable matrix for the in vivo cultivation of bone and cartilage |
| 03/31/2011 | US20110076308 Micelle encapsulation of therapeutic agents |
| 03/31/2011 | US20110076302 Plant-derived vaccines against respiratory syncytial virus |
| 03/31/2011 | US20110076299 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |